EUR 107.64 For Business Accounts Only

TBG Diagnostics Ltd - Strategic SWOT Analysis Review

TBG Diagnostics Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is a molecular diagnostics company that develops, manufactures and markets molecular diagnostics kits, instruments and services. The company’s major products include COVID 19 testing kits, nucleic acid extraction kits, HLA SBT typing kits, HPA genotyping kits, automated pipetting system, and gel electrophoresis. It serves clinical laboratories of hospitals and independent reference labs, blood centers, and bone marrow registry labs worldwide. It has research and development (R&D) facilities in the US, Taiwan and China and a manufacturing facility in Xiamen, China. The company has collaboration and product licensing agreements with various pharmaceutical companies and others. TBG Diagnostics is headquartered in Greenslopes, Queensland, Australia.

TBG Diagnostics Ltd Key Recent Developments

Mar 23,2021: TBG Diagnostics announces appointment of Mr.Bing-Cheng
Oct 30,2020: TBG Diagnostics: Quarterly activities report and appendix 4C

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.